A Case of Minimal Change Nephrotie Syndrome Associated with Diclofenac.
- Author:
Kyoung Bun PARK
1
;
Yo Seb HAN
;
Tae Won LEE
;
Myung Jae KIM
;
Moon Ho YANG
;
Chun Gyoo IHM
Author Information
1. Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Minimal change nephrotic syndrome;
Nonstroidal anti-inflammatory drugs;
Diclofenac
- MeSH:
Anti-Inflammatory Agents, Non-Steroidal;
Biopsy;
Cholesterol;
Creatinine;
Cytoplasm;
Diclofenac*;
Edema;
Eosinophils;
Female;
Filtration;
Fluorescent Antibody Technique;
Foot;
Furosemide;
Humans;
Hyperkalemia;
Immunoglobulin M;
Inflammation;
Knee;
Microscopy;
Middle Aged;
Necrosis;
Nephritis, Interstitial;
Nephrosis, Lipoid;
Potassium;
Recurrence;
Serologic Tests;
Serum Albumin;
Sodium;
Triglycerides;
Weight Gain
- From:Korean Journal of Nephrology
2000;19(3):547-551
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
NSAIDs are now the most widely prescribed of all drugs for the therapy of a large variety of disorders including rheumatologic disorders, and so the population of patients who are at risk for adverse effects of these drugs is rapidly expanding. A number of renal and electrolyte problems have been associated with the use of NSAIDs, including alterations in glome-rular filtration rate, hyperkalemia, acute interstitial nephritis and papillary necrosis. While the use of NSAIDs has also been associated with minimal change nephrotic syndrome, this complication has almost invariably occured in association with an acute interstitial nephritis. Recently, we experienced a case of minimal change nephrotic syndrome without significant interstitial inflammation associated with the use of NSAIDs. This patient is a 64-year-old female who developed the generalized edema and about 10kg of weight gain since three days ago. She had taken the anti-inflammatory drugs for five years intermittently and started taking diclofenac sodium, 25mg orally three times a day, 10 days before admission for increasing pain in her knees. Laboratory findings disclosed the following values WBC 5,200/mm3 with only 0.6% eosinophils, total serum protein 4.0g/dL, albumin 1.2 g/dL, BUN 17mg/dL, creatinine 0.8mg/dL, sodium 140 mmol/L, potassium 4.0mmol/L, chloride 113mmol/L, total cholesterol 338mg/dL, triglyceride 203mg/dL; 24-hour protein excretion 3.6g, creatinine clearance 52.8 mL/min ; serologic tests were unremarkable. A renal biopsy revealed no abnormality except for focal mild interstitial infiltration of chronic inflammatory cells with a few atrophic tubules on light microscopy. Immunofluorescence studies showed diffuse trace mesangial deposits of IgM, and electromicroscopy revealed diffuse obliteration of the epithelial foot process and villous transformation of the epitherial cell cytoplasms without electrondense deposits. These findings were consistent with minimal-change disease. Diclofenac was discontinued on admission because of the likelihood the renal disease was drugrelated and she treated with low-dose(40-80mg/d) of furosemide. Fourteen days after stopping diclofenac, her massive edema and weight gain resolved and laboratory studies showed a 24-hour urine protein excretion of 80mg and serum albumin of 2.7g/dL. There has been no relapse for five months since then.
